Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

Gainers

  • IceCure Medical Ltd ICCM shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
  • Exicure, Inc. XCUR shares rose 46% to $1.08 in pre-market trading. Exicure 10% owner CBI USA, Inc. acquired a total of 3,400,000 shares at an average price of $1.60.
  • Verona Pharma plc VRNA rose 39.3% to $18.80 in pre-market trading after the company reported positive results of its Phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease.
  • Otonomy, Inc OTIC rose 28.6% to $0.1475 in pre-market trading after the company issued a corporate update. The company said it approved and adopted plan of liquidation and dissolution, to include distribution of remaining cash to stockholders following orderly wind down of company's operations.
  • Inovio Pharmaceuticals, Inc. INO rose 18.5% to $1.85 in pre-market trading after dropping over 13% on Monday.
  • Healthcare Triangle, Inc. HCTI rose 18.4% to $0.3079 in pre-market trading after declining 16% on Monday. Healthcare Triangle, last month, posted a Q3 loss of $0.06 per share.
  • Metacrine, Inc. MTCR rose 17% to $0.4098 in pre-market trading. Tang Capital Partners reported in 13G filing a 7.1% stake in Metacrine.
  • Vallon Pharmaceuticals, Inc. VLON shares rose 16.5% to $0.3650 in pre-market trading. Vallon Pharmaceuticals and GRI Bio recently announced they entered into a merger agreement.
  • Sumitomo Mitsui Financial Group, Inc. SMFG rose 16% to $7.97 in pre-market trading.
  • Addex Therapeutics Ltd ADXN rose 15% to $0.69 in pre-market trading.
  • Surrozen, Inc. SRZN rose 12.5% to $0.5406 in pre-market trading after gaining 8% on Monday.
  • Mitsubishi UFJ Financial Group, Inc. MUFG rose 12.6% to $6.25 in pre-market trading.
  • OpGen, Inc. OPGN rose 12.5% to $0.1475 in pre-market trading. OpGen recently announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
  • Smart for Life, Inc. SMFL rose 11.5% to $0.2234 in pre-market trading after dropping 22% on Monday.
  • Baudax Bio, Inc. BXRX rose 10.9% to $2.04 in pre-market trading. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
  • NextDecade Corporation NEXT shares rose 10.1% to $4.55 in pre-market trading after dipping 7% on Monday.
  • Icosavax, Inc. ICVX rose 8.1% to $9.77 in pre-market trading after declining 9% on Monday. The company recently provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against respiratory syncytial virus


Don’t forget to check out our premarket coverage here .


Losers

  • Entrada Therapeutics Inc TRDA fell 32.1% to $13.50 in pre-market trading after the company said it received a clinical hold notice from the FDA regarding its Investigational New Drug Application for ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy.
  • Soleno Therapeutics, Inc. SLNO shares fell 24.3% to $1.40 in pre-market trading. Soleno Therapeutics shares jumped around 104% on Monday after the company announced a financing commitment for up to $60 million..
  • Axcella Health Inc. AXLA shares fell 22.7% to $0.3321 in pre-market trading after gaining 165% on Monday. Axcella Health recently announced organizational and program updates, including a reprioritization of its programs for Long COVID Fatigue and Nonalcoholic Steatohepatitis (NASH) and a restructuring of operations.
  • Crown ElectroKinetics Corp. CRKN fell 20.5% to $0.1410 in pre-market trading after dropping 13% on Monday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
  • Camber Energy, Inc. CEI fell 19.1% to $0.0867 in pre-market trading. Camber Energy shares jumped 73% on Monday after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split.
  • Caravelle International Group CACO fell 17.7% to $3.94 in pre-market trading after declining over 12% on Monday.
  • EUDA Health Holdings Limited EUDA fell 17.4% to $1.32 in pre-market trading after dropping more than 10% on Monday.
  • Hoth Therapeutics, Inc. HOTH fell 16.5% to $2.46 in pre-market trading after dropping 14% on Monday. Hoth Therapeutics recently announced submission of investigational new drug application for HT-001.
  • NantHealth, Inc. NH shares fell 15.9% to $3.54 in pre-market trading after dropping 26% on Monday. NantHealth recently announced a 1-for-15 reverse stock split.
  • HTG Molecular Diagnostics, Inc. HTGM shares fell 13.3% to $0.7125 in pre-market trading after jumping 49% on Monday.
  • Reed's, Inc. REED fell 13% to $0.0879 in pre-market trading after gaining around 35% on Monday.
  • AppTech Payments Corp. APCX fell 10.8% to $1.25 in pre-market trading after jumping 55% on Monday.
  • Shift Technologies, Inc. SFT fell 10.2% to $0.16 in pre-market trading after declining around 7% on Monday.
  • Gaotu Techedu Inc. GOTU fell 7.1% to $3.01 in pre-market trading. Gaotu Techedu, last month, reported a third-quarter FY22 sales decline of 45.6% year-on-year to RMB606.2 million ($85.21 million).
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!